Pages

Friday, March 20, 2015

VistaGen Therapeutics, Inc. (VSTA) Utilizing Stem Cell Technology to...

March 20, 2015 Unexpected cardiotoxicity, which damages the heart muscles, is among the most prevalent reasons for failure of both drugs and drug candidates. VistaGen Therapeutics, Inc. , through its customized cellular assay system, CardioSafe 3D , is working to enhance current testing practices and dramatically improve clinical predictability for new drugs.

http://ift.tt/1xHiyUq

No comments:

Post a Comment